Open Beta
MetriLume

US marketsCASIF

SEC-sourced researchBeta

CASIF

CASI Pharmaceuticals, Inc.

Company comparison ↗

Data passport

CIK
0001962738
Exchange
OTC
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
May 15, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 33,879,000.0000 USD; December 2024: 28,537,000.0000 USD; December 2025: 20,712,000.0000 USD33.9M USD0 USD0December 2023December 2024December 2025
CASIF · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202333,879,000.0000May 15, 2026
December 202428,537,000.0000May 15, 2026
December 202520,712,000.0000May 15, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202520,712,000.0000-48,058,000.0000-20,754,000.000025,650,000.000062,932,000.0000May 15, 2026
December 202428,537,000.0000-39,258,000.0000-29,224,000.000053,674,000.000051,823,000.0000May 15, 2026
December 202333,879,000.0000-26,960,000.0000-19,967,000.0000——May 15, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

25/100
Profitability0
Growth23
Balance sheet0
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$20.71MJan 1, 2025 – Dec 31, 2025May 15, 202620-F
Previous period revenueRevenues$28.54MJan 1, 2024 – Dec 31, 2024May 15, 202620-F
Net incomeNetIncomeLoss-$48.06MJan 1, 2025 – Dec 31, 2025May 15, 202620-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$20.75MJan 1, 2025 – Dec 31, 2025May 15, 202620-F
Total assetsAssets$25.65MDec 31, 2025May 15, 202620-F
Total liabilitiesLiabilities$62.93MDec 31, 2025May 15, 202620-F

New filings

No records match this view. You can broaden the filters.

Explore methodology ↗